Congratulations on a trade with Ritter Pharma (NASDAQ : RTTR). Today Ritter (Company) announced that the U.S. Food and Drug Administration (FDA) has agreed to schedule an end of phase 2 meeting with the company which is expected to take place in the third quarter of 2017. The Company plans to discuss the results of […]